ANTIBODY-MEDIATED REJECTION
Clinical trials for ANTIBODY-MEDIATED REJECTION explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-MEDIATED REJECTION trials appear
Sign up with your email to follow new studies for ANTIBODY-MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients facing rejection
Disease control Recruiting nowThis study tests a new drug called ALXN2030 in 45 adults who have had a kidney transplant and are experiencing antibody-mediated rejection (AMR). The goal is to see if the drug can help resolve signs of rejection seen on a kidney biopsy after one year of treatment. Participants w…
Matched conditions: ANTIBODY-MEDIATED REJECTION
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot could help kidney transplant patients fight rejection
Disease control Recruiting nowThis study tests a drug called efgartigimod, given as a shot under the skin, for people who have antibody-mediated rejection after a kidney transplant. The trial includes 30 adults who received a kidney at least 6 months ago and have signs of rejection. Participants will receive …
Matched conditions: ANTIBODY-MEDIATED REJECTION
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC